Company Filing History:
2 out of 1,780 
1 out of 76 
Years Active: 2015-2016
Title: Srividya Akella: Innovator in Genetic Engineering
Introduction
Srividya Akella is a prominent inventor based in San Diego, California. She has made significant contributions to the field of genetic engineering, particularly in the development of innovative methods for gene expression and lipid production. With a total of three patents to her name, her work has the potential to impact various biotechnological applications.
Latest Patents
One of her latest patents is titled "Autonomous replication sequences and episomal DNA molecules." This invention provides autonomous replication sequences (ARSs) that support the replication of episomal DNA molecules (EDMs) in eukaryotic cells. The ARSs and EDMs can be utilized for expressing genes in organisms, including algae and heterokonts. Another notable patent is focused on "Cell systems and methods for improving fatty acid synthesis by expression of dehydrogenases." This invention relates to methods for producing lipids, such as fatty acid products, in recombinant host cells engineered to express a non-native gene encoding a dehydrogenase. The recombinant microorganisms exhibit a higher proliferation rate compared to those that do not express the non-native dehydrogenase gene, leading to increased lipid production.
Career Highlights
Throughout her career, Srividya has worked with esteemed organizations, including ExxonMobil Research and Engineering Company and Synthetic Genomics, Inc. Her experience in these companies has allowed her to refine her skills and contribute to groundbreaking research in genetic engineering.
Collaborations
Srividya has collaborated with notable colleagues, including Peter DeHoff and Leah Soriaga. These partnerships have fostered an environment of innovation and creativity, further enhancing her contributions to the field.
Conclusion
In summary, Srividya Akella is a distinguished inventor whose work in genetic engineering has led to significant advancements in gene expression and lipid production. Her patents reflect her commitment to innovation and her impact on the biotechnology industry.